Authors' reply to Gandjour: "Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines".
Pharmacoeconomics
; 32(12): 1247, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-25374292
Subject(s)
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines
/
Mass Vaccination
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Pharmacoeconomics
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2014
Document type:
Article
Country of publication:
Nueva Zelanda